We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Share Name | Share Symbol | Market | Type | Share ISIN | Share Description |
---|---|---|---|---|---|
Gsk Plc | LSE:GSK | London | Ordinary Share | GB00BN7SWP63 | ORD 31 1/4P |
Price Change | % Change | Share Price | Bid Price | Offer Price | High Price | Low Price | Open Price | Shares Traded | Last Trade | |
---|---|---|---|---|---|---|---|---|---|---|
-20.50 | -1.27% | 1,590.00 | 1,588.50 | 1,589.50 | 1,603.00 | 1,576.50 | 1,598.00 | 7,586,333 | 16:35:08 |
Industry Sector | Turnover | Profit | EPS - Basic | PE Ratio | Market Cap |
---|---|---|---|---|---|
Pharmaceutical Preparations | 30.33B | 4.93B | 1.1970 | 13.27 | 65.42B |
TIDMGSK
RNS Number : 7706C
GlaxoSmithKline PLC
19 April 2017
GlaxoSmithKline plc (the 'Company')
Transaction notification
1. Details of PDMR/person closely associated with them ('PCA') === ========================================================================== a) Name Ms E Walmsley === ======================== ================================================ b) Position/status Chief Executive Officer === ======================== ================================================ c) Initial notification/ Initial notification amendment === ======================== ================================================ 2. Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor === ========================================================================== a) Name GlaxoSmithKline plc === ======================== ================================================ b) LEI 5493000HZTVUYLO1D793 === ======================== ================================================ 3. Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transaction(s) has been conducted === ========================================================================== a) Description of Ordinary shares of 25 pence each ('Ordinary the financial Shares') instrument ISIN: GB0009252882 === ======================== ================================================ b) Nature of the Increase in notional interest in Ordinary transaction Shares following the re-investment of dividends paid to shareholders on 13 April 2017 on Ordinary Shares held in the Company's 2009 Deferred Annual Bonus Plan. === ======================== ================================================ c) Price(s) and Price(s) Volume(s) volume(s) --------- -------------------------------- GBP16.47 82.730 (personal contribution) --------- -------------------------------- GBP16.47 204.873 (personal contribution) --------- -------------------------------- GBP16.47 223.059 (personal contribution) --------- -------------------------------- GBP16.47 82.730 (personal contribution) --------- -------------------------------- GBP16.47 204.858 (personal contribution) --------- -------------------------------- GBP16.47 223.045 (personal contribution) --------- -------------------------------- GBP16.47 82.730 (matching shares) --------- -------------------------------- GBP16.47 204.873 (matching shares) --------- -------------------------------- GBP16.47 223.059 (matching shares) --------- -------------------------------- GBP16.47 82.730 (matching shares) --------- -------------------------------- GBP16.47 204.858 (matching shares) --------- -------------------------------- GBP16.47 223.045 (matching shares) --------- -------------------------------- === ======================== ================================================ d) Aggregated information Aggregated volume Price 2,042.590 GBP16.47 === ======================== ================================================ e) Date of the transaction 2017-04-18 === ======================== ================================================ f) Place of the n/a transaction === ======================== ================================================ 1. Details of PDMR/person closely associated with them ('PCA') === ========================================================================== a) Name Mr R G Connor === ======================== ================================================ b) Position/status President, Global Manufacturing & Supply === ======================== ================================================ c) Initial notification/ Initial notification amendment === ======================== ================================================ 2. Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor === ========================================================================== a) Name GlaxoSmithKline plc === ======================== ================================================ b) LEI 5493000HZTVUYLO1D793 === ======================== ================================================ 3. Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transaction(s) has been conducted === ========================================================================== a) Description of Ordinary shares of 25 pence each ('Ordinary the financial Shares') instrument ISIN: GB0009252882 === ======================== ================================================ b) Nature of the Increase in notional interest in Ordinary transaction Shares following the re-investment of dividends paid to shareholders on 13 April 2017 on Ordinary Shares held in the Company's 2009 Deferred Annual Bonus Plan. === ======================== ================================================ c) Price(s) and Price(s) Volume(s) volume(s) --------- -------------------------------- GBP16.47 60.585 (personal contribution) --------- -------------------------------- GBP16.47 139.194 (personal contribution) --------- -------------------------------- GBP16.47 116.145 (personal contribution) --------- -------------------------------- GBP16.47 60.585 (personal contribution) --------- -------------------------------- GBP16.47 116.131 (personal contribution) --------- -------------------------------- GBP16.47 60.585 (matching shares) --------- -------------------------------- GBP16.47 139.194 (matching shares) --------- -------------------------------- GBP16.47 116.145 (matching shares) --------- -------------------------------- GBP16.47 60.585 (matching shares) --------- -------------------------------- GBP16.47 116.131 (personal contribution) --------- -------------------------------- === ======================== ================================================ d) Aggregated information Aggregated volume Price 985.280 GBP16.47 === ======================== ================================================ e) Date of the transaction 2017-04-18 === ======================== ================================================ f) Place of the n/a transaction === ======================== ================================================ 1. Details of PDMR/person closely associated with them ('PCA') === ========================================================================== a) Name Mr L Debruyne === ======================== ================================================ b) Position/status President, Global Vaccines === ======================== ================================================ c) Initial notification/ Initial notification amendment === ======================== ================================================ 2. Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor === ========================================================================== a) Name GlaxoSmithKline plc === ======================== ================================================ b) LEI 5493000HZTVUYLO1D793 === ======================== ================================================ 3. Details of the transaction(s): section to be repeated
for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transaction(s) has been conducted === ========================================================================== a) Description of Ordinary shares of 25 pence each ('Ordinary the financial Shares') instrument ISIN: GB0009252882 === ======================== ================================================ b) Nature of the Increase in notional interest in Ordinary transaction Shares following the re-investment of dividends paid to shareholders on 13 April 2017 on Ordinary Shares held in the Company's 2009 Deferred Annual Bonus Plan. === ======================== ================================================ c) Price(s) and Price(s) Volume(s) volume(s) --------- -------------------------------- GBP16.47 195.213 (personal contribution) --------- -------------------------------- GBP16.47 195.199 (personal contribution) --------- -------------------------------- GBP16.47 195.213 (matching shares) --------- -------------------------------- GBP16.47 195.199 (matching shares) --------- -------------------------------- === ======================== ================================================ d) Aggregated information Aggregated volume Price 780.824 GBP16.47 === ======================== ================================================ e) Date of the transaction 2017-04-18 === ======================== ================================================ f) Place of the n/a transaction === ======================== ================================================ 1. Details of PDMR/person closely associated with them ('PCA') === ========================================================================== a) Name Mr S Dingemans === ======================== ================================================ b) Position/status Chief Financial Officer === ======================== ================================================ c) Initial notification/ Initial notification amendment === ======================== ================================================ 2. Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor === ========================================================================== a) Name GlaxoSmithKline plc === ======================== ================================================ b) LEI 5493000HZTVUYLO1D793 === ======================== ================================================ 3. Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transaction(s) has been conducted === ========================================================================== a) Description of Ordinary shares of 25 pence each ('Ordinary the financial Shares') instrument ISIN: GB0009252882 === ======================== ================================================ b) Nature of the Increase in notional interest in Ordinary transaction Shares following the re-investment of dividends paid to shareholders on 13 April 2017 on Ordinary Shares held in the Company's 2009 Deferred Annual Bonus Plan. === ======================== ================================================ c) Price(s) and Price(s) Volume(s) volume(s) --------- -------------------------------- GBP16.47 115.556 (personal contribution) --------- -------------------------------- GBP16.47 270.551 (personal contribution) --------- -------------------------------- GBP16.47 202.642 personal contribution) --------- -------------------------------- GBP16.47 115.540 (personal contribution) --------- -------------------------------- GBP16.47 270.537 (personal contribution) --------- -------------------------------- GBP16.47 202.642 (personal contribution) --------- -------------------------------- GBP16.47 115.556 (matching shares) --------- -------------------------------- GBP16.47 270.551 (matching shares) --------- -------------------------------- GBP16.47 202.642 (matching shares) --------- -------------------------------- GBP16.47 115.540 (matching shares) --------- -------------------------------- GBP16.47 270.537 (matching shares) --------- -------------------------------- GBP16.47 202.642 (matching shares) --------- -------------------------------- === ======================== ================================================ d) Aggregated information Aggregated volume Price 2,354.936 GBP16.47 === ======================== ================================================ e) Date of the transaction 2017-04-18 === ======================== ================================================ f) Place of the n/a transaction === ======================== ================================================ 1. Details of PDMR/person closely associated with them ('PCA') === ========================================================================== a) Name Mr N Hirons === ======================== ================================================ b) Position/status SVP, Global Ethics & Compliance === ======================== ================================================ c) Initial notification/ Initial notification amendment === ======================== ================================================ 2. Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor === ========================================================================== a) Name GlaxoSmithKline plc === ======================== ================================================ b) LEI 5493000HZTVUYLO1D793 === ======================== ================================================ 3. Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transaction(s) has been conducted === ========================================================================== a) Description of Ordinary shares of 25 pence each ('Ordinary the financial Shares') instrument ISIN: GB0009252882 === ======================== ================================================ b) Nature of the Increase in notional interest in Ordinary transaction Shares following the re-investment of dividends paid to shareholders on 13 April 2017 on Ordinary Shares held in the Company's 2009 Deferred Annual Bonus Plan. === ======================== ================================================ c) Price(s) and Price(s) Volume(s) volume(s) --------- -------------------------------- GBP16.47 42.420 (personal contribution) --------- -------------------------------- GBP16.47 100.034 (personal contribution) --------- -------------------------------- GBP16.47 73.412 (personal contribution) --------- -------------------------------- GBP16.47 42.420 (personal contribution) --------- -------------------------------- GBP16.47 100.034 (personal contribution) --------- -------------------------------- GBP16.47 73.398 (personal contribution) --------- -------------------------------- GBP16.47 42.420 (matching shares) --------- -------------------------------- GBP16.47 100.034 (matching shares)
--------- -------------------------------- GBP16.47 73.412 (matching shares) --------- -------------------------------- GBP16.47 42.420 (matching shares) --------- -------------------------------- GBP16.47 100.034 (matching shares) --------- -------------------------------- GBP16.47 73.398 (matching shares) --------- -------------------------------- === ======================== ================================================ d) Aggregated information Aggregated volume Price 863.436 GBP16.47 === ======================== ================================================ e) Date of the transaction 2017-04-18 === ======================== ================================================ f) Place of the n/a transaction === ======================== ================================================ 1. Details of PDMR/person closely associated with them ('PCA') === ========================================================================== a) Name Mr S A Hussain === ======================== ================================================ b) Position/status President, Global Pharmaceuticals === ======================== ================================================ c) Initial notification/ Initial notification amendment === ======================== ================================================ 2. Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor === ========================================================================== a) Name GlaxoSmithKline plc === ======================== ================================================ b) LEI 5493000HZTVUYLO1D793 === ======================== ================================================ 3. Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transaction(s) has been conducted === ========================================================================== a) Description of Ordinary shares of 25 pence each ('Ordinary the financial Shares') instrument ISIN: GB0009252882 === ======================== ================================================ b) Nature of the Increase in notional interest in Ordinary transaction Shares following the re-investment of dividends paid to shareholders on 13 April 2017 on Ordinary Shares held in the Company's 2009 Deferred Annual Bonus Plan. === ======================== ================================================ c) Price(s) and Price(s) Volume(s) volume(s) --------- -------------------------------- GBP16.47 199.970 (personal contribution) --------- -------------------------------- GBP16.47 236.389 (personal contribution) --------- -------------------------------- GBP16.47 202.908 personal contribution) --------- -------------------------------- GBP16.47 236.389 (personal contribution) --------- -------------------------------- GBP16.47 202.894 (personal contribution) --------- -------------------------------- GBP16.47 199.970 (matching shares) --------- -------------------------------- GBP16.47 236.389 (matching shares) --------- -------------------------------- GBP16.47 202.908 (matching shares) --------- -------------------------------- GBP16.47 236.389 (matching shares) --------- -------------------------------- GBP16.47 202.894 (matching shares) --------- -------------------------------- === ======================== ================================================ d) Aggregated information Aggregated volume Price 2,157.100 GBP16.47 === ======================== ================================================ e) Date of the transaction 2017-04-18 === ======================== ================================================ f) Place of the n/a transaction === ======================== ================================================ 1. Details of PDMR/person closely associated with them ('PCA') === ========================================================================= a) Name Mr B McNamara === ======================== =============================================== b) Position/status CEO, GSK Consumer Healthcare === ======================== =============================================== c) Initial notification/ Initial notification amendment === ======================== =============================================== 2. Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor === ========================================================================= a) Name GlaxoSmithKline plc === ======================== =============================================== b) LEI 5493000HZTVUYLO1D793 === ======================== =============================================== 3. Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transaction(s) has been conducted === ========================================================================= a) Description of American Depositary Shares ('ADSs') the financial ISIN: US37733W1053 instrument === ======================== =============================================== b) Nature of the Increase in notional interest in ADSs following transaction the re-investment of dividends paid to shareholders on 13 April 2017 on ADSs held in the Company's 2009 Deferred Annual Bonus Plan. === ======================== =============================================== c) Price(s) and Price(s) Volume(s) volume(s) --------- ------------------------------- $41.81 82.979 (personal contribution) --------- ------------------------------- $41.81 82.979 (matching shares) --------- ------------------------------- === ======================== =============================================== d) Aggregated information Aggregated volume Price 165.958 $41.81 === ======================== =============================================== e) Date of the transaction 2017-04-18 === ======================== =============================================== f) Place of the n/a transaction === ======================== =============================================== 1. Details of PDMR/person closely associated with them ('PCA') === ========================================================================== a) Name Mr D S Redfern === ======================== ================================================ b) Position/status Chief Strategy Officer === ======================== ================================================ c) Initial notification/ Initial notification amendment === ======================== ================================================ 2. Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor === ========================================================================== a) Name GlaxoSmithKline plc === ======================== ================================================ b) LEI 5493000HZTVUYLO1D793 === ======================== ================================================ 3. Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transaction(s) has been conducted === ========================================================================== a) Description of Ordinary shares of 25 pence each ('Ordinary the financial Shares') instrument ISIN: GB0009252882 === ======================== ================================================
b) Nature of the Increase in notional interest in Ordinary transaction Shares following the re-investment of dividends paid to shareholders on 13 April 2017 on Ordinary Shares held in the Company's 2009 Deferred Annual Bonus Plan. === ======================== ================================================ c) Price(s) and Price(s) Volume(s) volume(s) --------- -------------------------------- GBP16.47 67.977 (personal contribution) --------- -------------------------------- GBP16.47 127.311 (personal contribution) --------- -------------------------------- GBP16.47 92.391 (personal contribution) --------- -------------------------------- GBP16.47 67.977 (personal contribution) --------- -------------------------------- GBP16.47 127.311 (personal contribution) --------- -------------------------------- GBP16.47 92.377 (personal contribution) --------- -------------------------------- GBP16.47 67.977 (matching shares) --------- -------------------------------- GBP16.47 127.311 (matching shares) --------- -------------------------------- GBP16.47 92.391 (matching shares) --------- -------------------------------- GBP16.47 67.977 (matching shares) --------- -------------------------------- GBP16.47 127.311 (matching shares) --------- -------------------------------- GBP16.47 92.377 (matching shares) --------- -------------------------------- === ======================== ================================================ d) Aggregated information Aggregated volume Price 1,150.688 GBP16.47 === ======================== ================================================ e) Date of the transaction 2017-04-18 === ======================== ================================================ f) Place of the n/a transaction === ======================== ================================================ 1. Details of PDMR/person closely associated with them ('PCA') === ========================================================================== a) Name Ms C Thomas === ======================== ================================================ b) Position/status SVP, Human Resources === ======================== ================================================ c) Initial notification/ Initial notification amendment === ======================== ================================================ 2. Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor === ========================================================================== a) Name GlaxoSmithKline plc === ======================== ================================================ b) LEI 5493000HZTVUYLO1D793 === ======================== ================================================ 3. Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transaction(s) has been conducted === ========================================================================== a) Description of Ordinary shares of 25 pence each ('Ordinary the financial Shares') instrument ISIN: GB0009252882 === ======================== ================================================ b) Nature of the Increase in notional interest in Ordinary transaction Shares following the re-investment of dividends paid to shareholders on 13 April 2017 on Ordinary Shares held in the Company's 2009 Deferred Annual Bonus Plan. === ======================== ================================================ c) Price(s) and Price(s) Volume(s) volume(s) --------- -------------------------------- GBP16.47 91.499 (personal contribution) --------- -------------------------------- GBP16.47 186.252 (personal contribution) --------- -------------------------------- GBP16.47 139.061(personal contribution) --------- -------------------------------- GBP16.47 91.483 (personal contribution) --------- -------------------------------- GBP16.47 186.252 (personal contribution) --------- -------------------------------- GBP16.47 139.061 (personal contribution) --------- -------------------------------- GBP16.47 91.499 (matching shares) --------- -------------------------------- GBP16.47 186.252 (matching shares) --------- -------------------------------- GBP16.47 139.061 (matching shares) --------- -------------------------------- GBP16.47 91.483 (matching shares) --------- -------------------------------- GBP16.47 186.252 (matching shares) --------- -------------------------------- GBP16.47 139.061 (matching shares) --------- -------------------------------- === ======================== ================================================ d) Aggregated information Aggregated volume Price 1,667.216 GBP16.47 === ======================== ================================================ e) Date of the transaction 2017-04-18 === ======================== ================================================ f) Place of the n/a transaction === ======================== ================================================ 1. Details of PDMR/person closely associated with them ('PCA') === ========================================================================== a) Name Mr P C Thomson === ======================== ================================================ b) Position/status President, Global Affairs === ======================== ================================================ c) Initial notification/ Initial notification amendment === ======================== ================================================ 2. Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor === ========================================================================== a) Name GlaxoSmithKline plc === ======================== ================================================ b) LEI 5493000HZTVUYLO1D793 === ======================== ================================================ 3. Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transaction(s) has been conducted === ========================================================================== a) Description of Ordinary shares of 25 pence each ('Ordinary the financial Shares') instrument ISIN: GB0009252882 === ======================== ================================================ b) Nature of the Increase in notional interest in Ordinary transaction Shares following the re-investment of dividends paid to shareholders on 13 April 2017 on Ordinary Shares held in the Company's 2009 Deferred Annual Bonus Plan. === ======================== ================================================ c) Price(s) and Price(s) Volume(s) volume(s) --------- -------------------------------- GBP16.47 62.146 (personal contribution) --------- -------------------------------- GBP16.47 113.955 (personal contribution) --------- -------------------------------- GBP16.47 87.545 (personal contribution)
--------- -------------------------------- GBP16.47 62.146 (matching shares) --------- -------------------------------- GBP16.47 113.955 (matching shares) --------- -------------------------------- GBP16.47 87.545 matching shares) --------- -------------------------------- === ======================== ================================================ d) Aggregated information Aggregated volume Price 527.292 GBP16.47 === ======================== ================================================ e) Date of the transaction 2017-04-18 === ======================== ================================================ f) Place of the n/a transaction === ======================== ================================================ 1. Details of PDMR/person closely associated with them ('PCA') === ========================================================================= a) Name Mr D E Troy === ======================== =============================================== b) Position/status SVP & General Counsel === ======================== =============================================== c) Initial notification/ Initial notification amendment === ======================== =============================================== 2. Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor === ========================================================================= a) Name GlaxoSmithKline plc === ======================== =============================================== b) LEI 5493000HZTVUYLO1D793 === ======================== =============================================== 3. Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transaction(s) has been conducted === ========================================================================= a) Description of American Depositary Shares ('ADSs') the financial ISIN: US37733W1053 instrument === ======================== =============================================== b) Nature of the Increase in notional interest in ADSs following transaction the re-investment of dividends paid to shareholders on 13 April 2017 on ADSs held in the Company's 2009 Deferred Annual Bonus Plan. === ======================== =============================================== c) Price(s) and Price(s) Volume(s) volume(s) --------- -------------------------------- $41.81 47.220 (personal contribution) --------- -------------------------------- $41.81 106.319 (personal contribution) --------- -------------------------------- $41.81 88.057 (personal contribution) --------- -------------------------------- $41.81 47.220 (personal contribution) --------- -------------------------------- $41.81 106.319 (personal contribution) --------- -------------------------------- $41.81 88.044 (personal contribution) --------- -------------------------------- $41.81 47.220 (matching shares) --------- -------------------------------- $41.81 106.319 (matching shares) --------- -------------------------------- $41.81 88.057 (matching shares) --------- -------------------------------- $41.81 47.220 (matching shares) --------- -------------------------------- $41.81 106.319 (matching shares) --------- -------------------------------- $41.81 88.044 (matching shares) --------- -------------------------------- === ======================== =============================================== d) Aggregated information Aggregated volume Price 966.358 $41.81 === ======================== =============================================== e) Date of the transaction 2017-04-18 === ======================== =============================================== f) Place of the n/a transaction === ======================== =============================================== 1. Details of PDMR/person closely associated with them ('PCA') === ========================================================================== a) Name Dr P J T Vallance === ======================== ================================================ b) Position/status President, R&D === ======================== ================================================ c) Initial notification/ Initial notification amendment === ======================== ================================================ 2. Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor === ========================================================================== a) Name GlaxoSmithKline plc === ======================== ================================================ b) LEI 5493000HZTVUYLO1D793 === ======================== ================================================ 3. Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transaction(s) has been conducted === ========================================================================== a) Description of Ordinary shares of 25 pence each ('Ordinary the financial Shares') instrument ISIN: GB0009252882 === ======================== ================================================ b) Nature of the Increase in notional interest in Ordinary transaction Shares following the re-investment of dividends paid to shareholders on 13 April 2017 on Ordinary Shares held in the Company's 2009 Deferred Annual Bonus Plan. === ======================== ================================================ c) Price(s) and Price(s) Volume(s) volume(s) --------- -------------------------------- GBP16.47 134.685 (personal contribution) --------- -------------------------------- GBP16.47 219.092 (personal contribution) --------- -------------------------------- GBP16.47 151.043 (personal contribution) --------- -------------------------------- GBP16.47 134.685 (personal contribution) --------- -------------------------------- GBP16.47 219.092 (personal contribution) --------- -------------------------------- GBP16.47 151.043 (personal contribution) --------- -------------------------------- GBP16.47 134.685 (matching shares) --------- -------------------------------- GBP16.47 219.092 (matching shares) --------- -------------------------------- GBP16.47 151.043 (matching shares) --------- -------------------------------- GBP16.47 134.685 (matching shares) --------- -------------------------------- GBP16.47 219.092 (matching shares) --------- -------------------------------- GBP16.47 151.043 (matching shares) --------- -------------------------------- === ======================== ================================================ d) Aggregated information Aggregated volume Price 2,019.280 GBP16.47 === ======================== ================================================ e) Date of the transaction 2017-04-18 === ======================== ================================================ f) Place of the n/a transaction
=== ======================== ================================================
This information is provided by RNS
The company news service from the London Stock Exchange
END
DSHEKLFFDZFBBBF
(END) Dow Jones Newswires
April 19, 2017 11:04 ET (15:04 GMT)
1 Year Gsk Chart |
1 Month Gsk Chart |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions